Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Tags › Posts tagged Pharmaceutical Industry

Tag: Pharmaceutical Industry

Shkreli pleads the Fifth, calls Congress ‘imbeciles’ Healthcare

Shkreli pleads the Fifth, calls Congress ‘imbeciles’

Robert King · February 4, 2016 3:16 pm
"The documents show that these tactics are not limited to a few 'bad apples,' but are prominent throughout the industry," he said in a statement. (AP File Photo/Molly Riley) Healthcare

Lawmakers to grill pharmaceutical companies, FDA on drug pricing

Robert King · February 4, 2016 5:01 am
Infamous pharmaceutical executive Martin Shkreli, center, will go before a House panel. Healthcare

Shkreli to take Fifth at House panel

Robert King · February 3, 2016 9:32 pm
Hillary Clinton got the most money from the pharmaceutical industry, double that of second-place Jeb Bush. (AP photo/Andrew Harnik) Healthcare

Big Pharma adores Clinton

Robert King · February 3, 2016 7:37 pm
"Very good. Nice work as usual. $1 [billion] here we come," read an email from former Turing Pharmaceuticals CEO Martin Shkreli to the company's board chairman. (AP file photo/Seth Wenig) Healthcare

Shkreli email shows gouging plan: ‘$1 billion here we come’

Robert King · February 2, 2016 3:58 pm
A big concern is the time it takes for generic drugs to be approved by the agency. (AP Photo/Gregory Bull) Healthcare

Senators want more from FDA on drug prices

Robert King · January 28, 2016 6:19 pm
Bill Clinton presided over the event, hosted by Sanofi and AstraZeneca. (Doug Benc/AP images for Humana, file)

Clinton Foundation hosts pharmaceutical executives on eve of Iowa caucus

Sarah Bedford · January 28, 2016 5:26 pm
Sanders holds up FDA nominee Healthcare

Sanders holds up FDA nominee

Robert King · January 26, 2016 4:27 pm
A federal judge ruled on Monday that Martin Shkreli, the former CEO of Turing Pharmaceuticals, can travel to Washington for the hearing on drug prices. (AP Photo) Healthcare

Shkreli can testify at postponed House drug price hearing

Robert King · January 25, 2016 5:32 pm
The Federal Trade Commission probe revealed Friday comes a few days after former CEO Martin Shkreli was subpoenaed by Congress to testify as part of a hearing. (AP Photo/Craig Ruttle, File) Healthcare

Controversial drug company faces fed probe

Robert King · January 22, 2016 8:49 pm
Martin Shkreli raised the price of an old anti-parasite treatment 5,000 percent in September. (AP Photo/Craig Ruttle) Healthcare

House subpoenas former Turing CEO

Robert King · January 20, 2016 8:49 pm
Prescriptions for opioids dropped 22 percent after new rules started, according to a new study. (AP Photo/Toby Talbot, File) Healthcare

Restrictions cut into painkiller prescriptions

Robert King · January 19, 2016 5:01 am
Advertisement
  • ‹Previous page
  • 1
  • …
  • 117
  • 118
  • 119
  • 120
  • 121
  • …
  • 142
  • ›Next page
Page 119 of 142
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement